Therapeutics on target:
Attacking cancer at the source

TM

DSC_1011.jpg

PanTher Therapeutics is a clinical-stage oncology company working to revolutionize the treatment of solid tumors.

​

Our minimally invasive implantable modality provides targeted and sustained localized cancer therapy, precisely directed at the intended site. 

About
​
Our mission is to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects.
More Info
Team
​
​PanTher is led by a multidisciplinary group of entrepreneurs, clinicians, researchers, engineers and business people.
More Info
News
 
Oct. 2021 - PanTher doses first two patients in Phase1 Trial of PTM-101
​
Aug. 2021 - PanTher gets approval to initiate Phase1 Trial in Australia and hires experienced CMO 
More Info
  • twitter-4-xxl
  • linkedin-4-xxl
  • email-14-xxl

© 2021 PanTher Therapeutics